Search research articles
Contact Us
Filters
Showing results (1-10 of 267) with videos related to
Page
of 27
Sort By:
The Journal of Clinical Investigation
|
August 15, 2022
Functional imaging of immune cell subpopulations in the tumor microenvironment: clinical implications
Amy B Heimberger
The Journal of Clinical Investigation
|
September 19, 2024
2024 Lasker Award Recipient Zhijian Chen elucidates how DNA stimulates immunity
Amy B Heimberger
Surgical Neurology International
|
December 6, 2011
The therapeutic potential of inhibitors of the signal transducer and activator of transcription 3 for central nervous system malignancies
Amy B Heimberger
Recent Patents on CNS Drug Discovery
|
November 11, 2008
Small molecular inhibitors of p-STAT3: novel agents for treatment of primary and metastatic CNS cancers
Amy B Heimberger, Waldemar Priebe
Neuro-Oncology
|
April 13, 2018
Comment on "Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma"
Hillary Caruso, Amy B Heimberger
Expert Review of Anticancer Therapy
|
October 14, 2005
Immunotherapy for human glioma: innovative approaches and recent results
S Farzana Hussain, Amy B Heimberger
Expert Opinion on Biological Therapy
|
July 14, 2009
The PEPvIII-KLH (CDX-110) vaccine in glioblastoma multiforme patients
Amy B Heimberger, John H Sampson
Neuro-Oncology
|
December 15, 2010
Immunotherapy coming of age: what will it take to make it standard of care for glioblastoma?
Amy B Heimberger, John H Sampson
The Journal of Clinical Investigation
|
January 17, 2023
The kynurenine pathway implicated in patient delirium: possible indications for indoleamine 2,3 dioxygenase inhibitors
Amy B Heimberger, Rimas V Lukas
Cells
|
August 27, 2021
Immune Microenvironment Landscape in CNS Tumors and Role in Responses to Immunotherapy
Hinda Najem, Mustafa Khasraw, Amy B Heimberger
Page
of 27
Search research articles
Search
Showing results (1-10 of 267) with videos related to
Sort By:
Page
of 27
The Journal of Clinical Investigation
|
August 15, 2022
Functional imaging of immune cell subpopulations in the tumor microenvironment: clinical implications
Amy B Heimberger
The Journal of Clinical Investigation
|
September 19, 2024
2024 Lasker Award Recipient Zhijian Chen elucidates how DNA stimulates immunity
Amy B Heimberger
Surgical Neurology International
|
December 6, 2011
The therapeutic potential of inhibitors of the signal transducer and activator of transcription 3 for central nervous system malignancies
Amy B Heimberger
Recent Patents on CNS Drug Discovery
|
November 11, 2008
Small molecular inhibitors of p-STAT3: novel agents for treatment of primary and metastatic CNS cancers
Amy B Heimberger, Waldemar Priebe
Neuro-Oncology
|
April 13, 2018
Comment on "Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma"
Hillary Caruso, Amy B Heimberger
Expert Review of Anticancer Therapy
|
October 14, 2005
Immunotherapy for human glioma: innovative approaches and recent results
S Farzana Hussain, Amy B Heimberger
Expert Opinion on Biological Therapy
|
July 14, 2009
The PEPvIII-KLH (CDX-110) vaccine in glioblastoma multiforme patients
Amy B Heimberger, John H Sampson
Neuro-Oncology
|
December 15, 2010
Immunotherapy coming of age: what will it take to make it standard of care for glioblastoma?
Amy B Heimberger, John H Sampson
The Journal of Clinical Investigation
|
January 17, 2023
The kynurenine pathway implicated in patient delirium: possible indications for indoleamine 2,3 dioxygenase inhibitors
Amy B Heimberger, Rimas V Lukas
Cells
|
August 27, 2021
Immune Microenvironment Landscape in CNS Tumors and Role in Responses to Immunotherapy
Hinda Najem, Mustafa Khasraw, Amy B Heimberger
Page
of 27